Incidence of infections due to third generation cephalosporin-resistant - a prospective multicentre cohort study in six German university hospitals

Standard

Incidence of infections due to third generation cephalosporin-resistant - a prospective multicentre cohort study in six German university hospitals. / Rohde, Anna M; Zweigner, Janine; Wiese-Posselt, Miriam; Schwab, Frank; Behnke, Michael; Kola, Axel; Obermann, Birgit; Knobloch, Johannes K-M; Feihl, Susanne; Querbach, Christiane; Gebhardt, Friedemann; Mischnik, Alexander; Ihle, Vera; Schröder, Wiebke; Armean, Sabina; Peter, Silke; Tacconelli, Evelina; Hamprecht, Axel; Seifert, Harald; Vehreschild, Maria J G T; Kern, Winfried V; Gastmeier, Petra; DZIF-ATHOS Study Group .

In: ANTIMICROB RESIST IN, Vol. 7, 2018, p. 159.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Rohde, AM, Zweigner, J, Wiese-Posselt, M, Schwab, F, Behnke, M, Kola, A, Obermann, B, Knobloch, JK-M, Feihl, S, Querbach, C, Gebhardt, F, Mischnik, A, Ihle, V, Schröder, W, Armean, S, Peter, S, Tacconelli, E, Hamprecht, A, Seifert, H, Vehreschild, MJGT, Kern, WV, Gastmeier, P & DZIF-ATHOS Study Group 2018, 'Incidence of infections due to third generation cephalosporin-resistant - a prospective multicentre cohort study in six German university hospitals', ANTIMICROB RESIST IN, vol. 7, pp. 159. https://doi.org/10.1186/s13756-018-0452-8

APA

Rohde, A. M., Zweigner, J., Wiese-Posselt, M., Schwab, F., Behnke, M., Kola, A., Obermann, B., Knobloch, J. K-M., Feihl, S., Querbach, C., Gebhardt, F., Mischnik, A., Ihle, V., Schröder, W., Armean, S., Peter, S., Tacconelli, E., Hamprecht, A., Seifert, H., ... DZIF-ATHOS Study Group (2018). Incidence of infections due to third generation cephalosporin-resistant - a prospective multicentre cohort study in six German university hospitals. ANTIMICROB RESIST IN, 7, 159. https://doi.org/10.1186/s13756-018-0452-8

Vancouver

Bibtex

@article{6f576cf7e47e4b8c93be8972d10783d6,
title = "Incidence of infections due to third generation cephalosporin-resistant - a prospective multicentre cohort study in six German university hospitals",
abstract = "Background: Infections caused by third generation cephalosporin-resistant Enterobacteriaceae (3GCREB) are an increasing healthcare problem. We aim to describe the 3GCREB infection incidence and compare it to prevalence upon admission. In addition, we aim to describe infections caused by 3GCREB, which are also carbapenem resistant (CRE).Methods: In 2014-2015, we performed prospective 3GCREB surveillance in clinically relevant patient specimens (screening specimens excluded). Infections counted as hospital-acquired (HAI) when the 3GCREB was detected after the third day following admission, otherwise as community-acquired infection (CAI).Results: Of 578,420 hospitalized patients under surveillance, 3367 had a 3GCREB infection (0.58%). We observed a similar 3GCREB CAI and HAI incidence (0.28 and 0.31 per 100 patients, respectively). The most frequent pathogen was 3GCR E. coli, in CAI and HAI (0.15 and 0.12 per 100 patients). We observed a CRE CAI incidence of 0.006 and a HAI incidence of 0.008 per 100 patients (0.014 per 1000 patient days).Conclusions: Comparing the known 3GCREB admission prevalence of the participating hospitals (9.5%) with the percentage of patients with a 3GCREB infection (0.58%), we conclude the prevalence of 3GCREB in university hospitals to be about 16 times higher than suggested when only patients with 3GCREB infections are considered. Moreover, we find the HAI and CAI incidence caused by CRE in Germany to be relatively low.",
keywords = "Journal Article",
author = "Rohde, {Anna M} and Janine Zweigner and Miriam Wiese-Posselt and Frank Schwab and Michael Behnke and Axel Kola and Birgit Obermann and Knobloch, {Johannes K-M} and Susanne Feihl and Christiane Querbach and Friedemann Gebhardt and Alexander Mischnik and Vera Ihle and Wiebke Schr{\"o}der and Sabina Armean and Silke Peter and Evelina Tacconelli and Axel Hamprecht and Harald Seifert and Vehreschild, {Maria J G T} and Kern, {Winfried V} and Petra Gastmeier and {DZIF-ATHOS Study Group}",
year = "2018",
doi = "10.1186/s13756-018-0452-8",
language = "English",
volume = "7",
pages = "159",
journal = "ANTIMICROB RESIST IN",
issn = "2047-2994",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Incidence of infections due to third generation cephalosporin-resistant - a prospective multicentre cohort study in six German university hospitals

AU - Rohde, Anna M

AU - Zweigner, Janine

AU - Wiese-Posselt, Miriam

AU - Schwab, Frank

AU - Behnke, Michael

AU - Kola, Axel

AU - Obermann, Birgit

AU - Knobloch, Johannes K-M

AU - Feihl, Susanne

AU - Querbach, Christiane

AU - Gebhardt, Friedemann

AU - Mischnik, Alexander

AU - Ihle, Vera

AU - Schröder, Wiebke

AU - Armean, Sabina

AU - Peter, Silke

AU - Tacconelli, Evelina

AU - Hamprecht, Axel

AU - Seifert, Harald

AU - Vehreschild, Maria J G T

AU - Kern, Winfried V

AU - Gastmeier, Petra

AU - DZIF-ATHOS Study Group

PY - 2018

Y1 - 2018

N2 - Background: Infections caused by third generation cephalosporin-resistant Enterobacteriaceae (3GCREB) are an increasing healthcare problem. We aim to describe the 3GCREB infection incidence and compare it to prevalence upon admission. In addition, we aim to describe infections caused by 3GCREB, which are also carbapenem resistant (CRE).Methods: In 2014-2015, we performed prospective 3GCREB surveillance in clinically relevant patient specimens (screening specimens excluded). Infections counted as hospital-acquired (HAI) when the 3GCREB was detected after the third day following admission, otherwise as community-acquired infection (CAI).Results: Of 578,420 hospitalized patients under surveillance, 3367 had a 3GCREB infection (0.58%). We observed a similar 3GCREB CAI and HAI incidence (0.28 and 0.31 per 100 patients, respectively). The most frequent pathogen was 3GCR E. coli, in CAI and HAI (0.15 and 0.12 per 100 patients). We observed a CRE CAI incidence of 0.006 and a HAI incidence of 0.008 per 100 patients (0.014 per 1000 patient days).Conclusions: Comparing the known 3GCREB admission prevalence of the participating hospitals (9.5%) with the percentage of patients with a 3GCREB infection (0.58%), we conclude the prevalence of 3GCREB in university hospitals to be about 16 times higher than suggested when only patients with 3GCREB infections are considered. Moreover, we find the HAI and CAI incidence caused by CRE in Germany to be relatively low.

AB - Background: Infections caused by third generation cephalosporin-resistant Enterobacteriaceae (3GCREB) are an increasing healthcare problem. We aim to describe the 3GCREB infection incidence and compare it to prevalence upon admission. In addition, we aim to describe infections caused by 3GCREB, which are also carbapenem resistant (CRE).Methods: In 2014-2015, we performed prospective 3GCREB surveillance in clinically relevant patient specimens (screening specimens excluded). Infections counted as hospital-acquired (HAI) when the 3GCREB was detected after the third day following admission, otherwise as community-acquired infection (CAI).Results: Of 578,420 hospitalized patients under surveillance, 3367 had a 3GCREB infection (0.58%). We observed a similar 3GCREB CAI and HAI incidence (0.28 and 0.31 per 100 patients, respectively). The most frequent pathogen was 3GCR E. coli, in CAI and HAI (0.15 and 0.12 per 100 patients). We observed a CRE CAI incidence of 0.006 and a HAI incidence of 0.008 per 100 patients (0.014 per 1000 patient days).Conclusions: Comparing the known 3GCREB admission prevalence of the participating hospitals (9.5%) with the percentage of patients with a 3GCREB infection (0.58%), we conclude the prevalence of 3GCREB in university hospitals to be about 16 times higher than suggested when only patients with 3GCREB infections are considered. Moreover, we find the HAI and CAI incidence caused by CRE in Germany to be relatively low.

KW - Journal Article

U2 - 10.1186/s13756-018-0452-8

DO - 10.1186/s13756-018-0452-8

M3 - SCORING: Journal article

C2 - 30603083

VL - 7

SP - 159

JO - ANTIMICROB RESIST IN

JF - ANTIMICROB RESIST IN

SN - 2047-2994

ER -